A Community-Based Trial of Commercially Available Compression Tights in Patients With Postural Orthostatic Tachycardia Syndrome.
Kate M Bourne, Kavithra Karalasingham, Tanya Siddiqui...
https://pubmed.ncbi.nlm.nih.gov/39614865/Actively Recruiting
Led by University of Calgary · Updated on 2026-05-07
30
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the use of commercially available waist-high and abdominal compression garments for adults diagnosed with Postural Orthostatic Tachycardia Syndrome POTS to see if they improve heart rate and reduce symptoms in a community setting. POTS treatments include medications and non-drug methods like exercise and compression garments, but the effectiveness of everyday compression garments outside a lab is not well known. This trial aims to provide evidence on their practical use for managing POTS symptoms at home. Participants will use commercially or medically available waist-high compression tights applying 15-40 mmHg pressure, and optionally abdominal compression garments that cover the abdomen, buttocks, and upper thighs. The study includes two 2-day phases with a 5-day washout in between one with regular medications affecting heart rate and blood pressure, and one without. Participants will be randomly assigned to wear compression garments with or without medications first, and for those in the abdominal compression sub-study, the order of garment use will also be randomized. During each study day, participants will wear a Holter monitor and perform four standing tests spaced by specific intervals before, during, and after wearing the compression garment. They will record symptoms and medications daily in a study booklet. Researchers will measure heart rate changes to assess the garments effects. The total participation time is up to 4 days, with monitoring conducted in the participants usual environment to reflect real-life use.
CONDITIONS
Compression Garments in the Community With POTS
K
Kate M Bourne, BSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Calgary
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 4 days in total
Participants will wear compression garments in the community setting to evaluate their effectiveness in reducing orthostatic tachycardia. They will undergo periods with and without their regular medications and complete standing tests while wearing a Holter monitor.
4 study days with 4 standing tests each day
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Kate M Bourne, Kavithra Karalasingham, Tanya Siddiqui...
https://pubmed.ncbi.nlm.nih.gov/39614865/Kate M Bourne, Kavithra Karalasingham, Tanya Siddiqui...
https://pubmed.ncbi.nlm.nih.gov/41338488/University of Calgary
Lead Sponsor